These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome. Srikanth S; Deedwania P Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495 [TBL] [Abstract][Full Text] [Related]
6. Do statins reduce events in patients with metabolic syndrome? Towne SP; Thara E Curr Atheroscler Rep; 2008 Feb; 10(1):39-44. PubMed ID: 18366984 [TBL] [Abstract][Full Text] [Related]
7. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome. Ferdinand KC J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832 [TBL] [Abstract][Full Text] [Related]
8. Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome. Gaesser GA Curr Diab Rep; 2007 Feb; 7(1):14-9. PubMed ID: 17254513 [TBL] [Abstract][Full Text] [Related]
9. Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome. Arca M Drugs; 2007; 67 Suppl 1():43-54. PubMed ID: 17910520 [TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Vuppalanchi R; Chalasani N Hepatology; 2009 Jan; 49(1):306-17. PubMed ID: 19065650 [TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome: is it a syndrome? Does it matter? Kahn R Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171 [No Abstract] [Full Text] [Related]
13. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome. Chen J; Townsend RR Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes. Rosenson RS; Reasner CA Curr Opin Cardiol; 2004 Sep; 19(5):480-7. PubMed ID: 15316457 [TBL] [Abstract][Full Text] [Related]
15. The role of statins in managing diabetic dyslipidemia. Toth PP J Fam Pract; 2010 May; 59(5 Suppl):S23-9. PubMed ID: 20544054 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of interventions for the reversal of a metabolic syndrome diagnosis: An update of a meta-analysis of mixed treatment comparison studies. Guzmán A; Navarro E; Obando L; Pacheco J; Quirós K; Vásquez L; Castro M; Ramírez F Biomedica; 2019 Dec; 39(4):647-662. PubMed ID: 31860177 [TBL] [Abstract][Full Text] [Related]
17. High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy. Gonzalez GL; Manrique CM; Sowers JR J Cardiometab Syndr; 2006; 1(3):178-83. PubMed ID: 17679817 [TBL] [Abstract][Full Text] [Related]
19. Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials. Armitage J; Collins R Heart; 2000 Oct; 84(4):357-60. PubMed ID: 10995396 [No Abstract] [Full Text] [Related]
20. Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome. López-Jaramillo P; Barbosa E; Molina DI; Sanchez R; Diaz M; Camacho PA; Lanas F; Pasquel M; Accini JL; Ponte-Negretti CI; Alcocer L; Cobos L; Wyss F; Sebba-Barroso W; Coca A; Zanchetti A; J Hypertens; 2019 Jun; 37(6):1126-1147. PubMed ID: 30882601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]